Regulatory, Medical Legal and Reimbursement Considerations for AI Tools in Clinical Practice
Description & Learning Objectives
Presented by the ASNR AI Committee.
Upon completion of this activity, participants will gain strategies to:
-Describe FDA clearance pathways that govern AI-enabled imaging software, including indications for use & oversight of algorithm changes after market entry.
-Identify sources of liability associated with clinical AI use, including evolving SOC, responsibility allocation among vendors, institutions, & interpreting physicians, & medical record documentation of AI outputs.
-Recognize how bias enters AI models through training data and validation design & describe methods for reducing bias, assessing performance across patient populations & monitoring for drift after deployment.
-Discuss privacy obligations surrounding AI tools, including HIPAA considerations, de-identification standards, & patient data use for model training.
-Explain current reimbursement pathways for imaging AI tools, including CPT coding categories, add-on payment mechanisms, payer coverage variability, & return on investment.
Upon completion of this activity, participants will gain strategies to:
-Describe FDA clearance pathways that govern AI-enabled imaging software, including indications for use & oversight of algorithm changes after market entry.
-Identify sources of liability associated with clinical AI use, including evolving SOC, responsibility allocation among vendors, institutions, & interpreting physicians, & medical record documentation of AI outputs.
-Recognize how bias enters AI models through training data and validation design & describe methods for reducing bias, assessing performance across patient populations & monitoring for drift after deployment.
-Discuss privacy obligations surrounding AI tools, including HIPAA considerations, de-identification standards, & patient data use for model training.
-Explain current reimbursement pathways for imaging AI tools, including CPT coding categories, add-on payment mechanisms, payer coverage variability, & return on investment.
Instructions for Participation
To complete this activity, learners will watch a recording of a live webinar and submit a course evaluation. Once all elements are completed, a certificate will be automatically added to your transcript.
Credit Dates
Available: 9/18/2026
Expires: 9/17/2029
Expires: 9/17/2029
Planners & Faculty
Suzie Bash, MD, Planner/Moderator
Ryan Lee, MD, MBA, Moderator
Melissa Chen, MD, Speaker
Jacob Ormsby, MD, MBA, Speaker
Ryan Lee, MD, MBA, Moderator
Melissa Chen, MD, Speaker
Jacob Ormsby, MD, MBA, Speaker
Accreditation Statement
The American Society of Neuroradiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Neuroradiology designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society of Neuroradiology designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure
In compliance with ACCME requirements and guidelines, ASNR has developed a policy for disclosure and review of potential conflicts of interest and a method for resolution if a conflict does exist. ASNR maintains a tradition of scientific integrity and objectivity in its educational activities. In order to preserve these values and ensure its educational activities are independent and free of commercial bias, all individuals, including planners, presenters, moderators and evaluators, participating in an ASNR educational activity, or an activity jointly provided by ASNR must disclose all relevant financial relationships with ineligible companies, as defined by the ACCME. Unless listed below, all planners and individuals in control of content have nothing to disclose.
Suzie Bash:
Viz.ai: Board of Directors or Scientific/Medical Advisory Board
GE Healthcare: Speaking and/or Teaching Arrangements
Siemens: Speaking and/or Teaching Arrangements
Cortechs.ai: Board of Directors or Scientific/Medical Advisory Board
Subtle Medical: Board of Directors or Scientific/Medical Advisory Board
Eisai: Speaking and/or Teaching Arrangements
Darmiyan: Consulting
Fuji: Consulting
Melissa Chen:
Guerbet: Speaking and/or Teaching Arrangements
Suzie Bash:
Viz.ai: Board of Directors or Scientific/Medical Advisory Board
GE Healthcare: Speaking and/or Teaching Arrangements
Siemens: Speaking and/or Teaching Arrangements
Cortechs.ai: Board of Directors or Scientific/Medical Advisory Board
Subtle Medical: Board of Directors or Scientific/Medical Advisory Board
Eisai: Speaking and/or Teaching Arrangements
Darmiyan: Consulting
Fuji: Consulting
Melissa Chen:
Guerbet: Speaking and/or Teaching Arrangements
